Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.

@article{Garca2014ManagementAC,
  title={Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.},
  author={David Antol{\'i}n Garc{\'i}a and John Hunter Alexander and Lars Wallentin and Daniel Wojdyla and Laine E Thomas and Michael G. Hanna and Sana M. Al-Khatib and P. Dorian and Jack Ansell and Patrick Joseph Commerford and Greg C. Flaker and Fernando Lanas and Dragoș Vinereanu and Denis Xavier and Elaine M. Hylek and Claes Held and Freek W. A. Verheugt and Christopher B. Granger and Renato D Lopes},
  journal={Blood},
  year={2014},
  volume={124 25},
  pages={
          3692-8
        }
}
Using data from ARISTOTLE, we describe the periprocedural management of anticoagulation and rates of subsequent clinical outcomes among patients chronically anticoagulated with warfarin or apixaban. We recorded whether (and for how long) anticoagulant therapy was interrupted preprocedure, whether bridging therapy was used, and the proportion of patients who experienced important clinical outcomes during the 30 days postprocedure. Of 10 674 procedures performed during follow-up in 5924 patients… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 47 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 11 REFERENCES

Eliquis (apixaban) package insert

  • Granger, Denis Xavier, +13 authors Michael Hanna
  • http:// packageinserts.bms.com/pi/pi_eliquis.pdf…
  • 2014

Similar Papers

Loading similar papers…